Diabetes Drugs Emerge as Top Force in Drug Spend... ( - Generics Lead to Plunge in Choleste...)

Diabetes Drugs Emerge as Top Force in Drug Spending Growth

Date:5/15/2008

- Generics Lead to Plunge in Cholesterol Drug Spending Despite Higher Use -

- Cancer Drug Spending Seen Surging 46-53 Percent Through 2010 -

- Drug Trend Drops to All-time Low 2 Percent -

FRANKLIN LAKES, N.J., May 15 /PRNewswire-FirstCall/ -- Diabetes treatments are now the leading driver of prescription drug spending growth, displacing lipid-lowering drugs which fell precipitously after a decade of reigning in the top position, as generic drugs cut the cost of treating high cholesterol. These new findings were reported by Medco Health Solutions Inc. (NYSE: MHS), the nation's leading pharmacy benefit manager, in its just-released 2008 Drug Trend Report, a comprehensive analysis of prescription drug spending and utilization.

The report shows that despite continued growth in the use of cholesterol drugs, spending fell 8.5 percent in 2007 as usage of lower-cost generic versions of Pravachol and Zocor expanded in the marketplace, resulting in lipid-lowering medications experiencing the greatest spending decline of all drug categories. Meanwhile, spending on diabetes drugs increased 12 percent due to shifts toward higher-cost treatments, brand-name drug price inflation, and moderate growth in the number of patients receiving treatment.

For a decade, cholesterol drugs were the largest driver of drug trend -- a measure of spending growth for pharmacy benefit plans. These medications still account for a sizable 10.8 percent of all prescription costs with utilization rising 5.9 percent last year as new clinical guidelines expanded the population that can benefit from these treatments.

"Generic drugs have been a tremendous asset in controlling runaway health care costs," Medco Chairman and CEO David B
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. AUDIO from Medialink and Eli Lilly and Company: F.A.C.E. Diabetes
2. International Diabetes Federation gives grant to metabolic syndrome research project in Australia
3. Chrysler LLC Vice Chairman and President Jim Press and His Wife Suwichada Serve as Honorary Co-Chairs of Annual Juvenile Diabetes Research Foundation Promise Ball
4. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
5. Market Research Shows Spherixs Naturlose(R) Readily Accepted by Diabetes Patients
6. Suspected cause of type 1 diabetes caught red-handed for the first time
7. Fetal Gene May Contribute to Diabetes Risk
8. New report: Arthritis is a potential barrier to physical activity for adults with diabetes
9. International Diabetes Federation gives grant to Philippine diabetes education program
10. Leading Advocacy Groups Set National Diabetes Goal
11. Diabetes Seems to Heighten Glaucoma Risk

Post Your Comments:

Diabetes Drugs Emerge as Top Force in Drug Spend...( - Generics Lead to Plunge in Choleste...),Health